KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alnylam Pharmaceuticals (ALNY) Net Cash Flow (2017 - 2026)

Alnylam Pharmaceuticals (ALNY) has disclosed Net Cash Flow for 18 consecutive years, with $60.7 million as the latest value for Q1 2026.

  • For Q1 2026, Net Cash Flow rose 53.46% year-over-year to $60.7 million; the TTM value through Mar 2026 reached $676.4 million, up 105.72%, while the annual FY2025 figure was $655.2 million, 287.69% up from the prior year.
  • Net Cash Flow hit $60.7 million in Q1 2026 for Alnylam Pharmaceuticals, down from $171.7 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $495.6 million in Q3 2022 and bottomed at -$283.7 million in Q1 2022.
  • Average Net Cash Flow over 5 years is $51.7 million, with a median of $50.3 million recorded in 2022.
  • Year-over-year, Net Cash Flow crashed 150.73% in 2022 and then soared 2124.43% in 2024.
  • Alnylam Pharmaceuticals' Net Cash Flow stood at -$208.5 million in 2022, then dropped by 10.92% to -$231.2 million in 2023, then surged by 49.58% to -$116.6 million in 2024, then skyrocketed by 247.29% to $171.7 million in 2025, then tumbled by 64.66% to $60.7 million in 2026.
  • According to Business Quant data, Net Cash Flow over the past three periods came in at $60.7 million, $171.7 million, and $377.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.